Last reviewed · How we verify
Neural Stem Cells-expressing CRAd-S-pk7 — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Neural Stem Cells-expressing CRAd-S-pk7 (Neural Stem Cells-expressing CRAd-S-pk7) — City of Hope Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Neural Stem Cells-expressing CRAd-S-pk7 TARGET | Neural Stem Cells-expressing CRAd-S-pk7 | City of Hope Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Neural Stem Cells-expressing CRAd-S-pk7 CI watch — RSS
- Neural Stem Cells-expressing CRAd-S-pk7 CI watch — Atom
- Neural Stem Cells-expressing CRAd-S-pk7 CI watch — JSON
- Neural Stem Cells-expressing CRAd-S-pk7 alone — RSS
Cite this brief
Drug Landscape (2026). Neural Stem Cells-expressing CRAd-S-pk7 — Competitive Intelligence Brief. https://druglandscape.com/ci/neural-stem-cells-expressing-crad-s-pk7. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab